Skip to Content

Resource • White Paper

Program Optimization:

Optimizing Ophthalmic CE ANDA Trials

July 12th, 2017 | Clinical Trials | Ophthalmology | Program Development | White Paper

Program Optimization:

Optimizing Ophthalmic CE ANDA Trials

Achieving optimization in CE trials means engaging in careful analysis and decision-making throughout the entire process. CE studies represent a significant expense for sponsors in both time and money. The process of designing and running CE studies is wrought with choices, decisions, tradeoffs and challenge. Explore Biorasi’s vision to achieving successful CE ANDA clinical programs in ophthalmology.

Panel of Experts

  • Michael Pohl
    Associate Director of Program Development and Head of the Neurology and Regenerative Medicine Center of Excellence, SCORR Marketing

Get Access to this White Paper Now

Related Resources

White Paper

HEPATOCELLULAR CARCINOMA: Consider India for your next HCC international trial

White Paper

Rare Disease: 5 Steps to Successful Program Development

View All